SI3969445T1 - Postopek priprave n-[4-(klorodifluorometoksi)fenil]-6-[(3r)-3-hidroksipirolidin-1-il]-5-(1h-pirazol-5-il)piridin-3-karboksamida - Google Patents

Postopek priprave n-[4-(klorodifluorometoksi)fenil]-6-[(3r)-3-hidroksipirolidin-1-il]-5-(1h-pirazol-5-il)piridin-3-karboksamida

Info

Publication number
SI3969445T1
SI3969445T1 SI202030586T SI202030586T SI3969445T1 SI 3969445 T1 SI3969445 T1 SI 3969445T1 SI 202030586 T SI202030586 T SI 202030586T SI 202030586 T SI202030586 T SI 202030586T SI 3969445 T1 SI3969445 T1 SI 3969445T1
Authority
SI
Slovenia
Prior art keywords
chlorodifluoromethoxy
hydroxypyrrolidin
pyrazol
carboxamide
pyridine
Prior art date
Application number
SI202030586T
Other languages
English (en)
Inventor
Jarred Blank
Christian Koecher
Werner Heinz Pachinger
Galatea Paredes
Markus Spaeti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SI3969445T1 publication Critical patent/SI3969445T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI202030586T 2019-05-16 2020-05-15 Postopek priprave n-[4-(klorodifluorometoksi)fenil]-6-[(3r)-3-hidroksipirolidin-1-il]-5-(1h-pirazol-5-il)piridin-3-karboksamida SI3969445T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962848869P 2019-05-16 2019-05-16
US201962929995P 2019-11-04 2019-11-04
EP20726960.6A EP3969445B1 (en) 2019-05-16 2020-05-15 Process for the preparation of n-[4-(chlorodifluoromethoxy)phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-5-yl)pyridine-3-carboxamide
PCT/IB2020/054629 WO2020230100A1 (en) 2019-05-16 2020-05-15 Chemical process

Publications (1)

Publication Number Publication Date
SI3969445T1 true SI3969445T1 (sl) 2025-05-30

Family

ID=70775450

Family Applications (1)

Application Number Title Priority Date Filing Date
SI202030586T SI3969445T1 (sl) 2019-05-16 2020-05-15 Postopek priprave n-[4-(klorodifluorometoksi)fenil]-6-[(3r)-3-hidroksipirolidin-1-il]-5-(1h-pirazol-5-il)piridin-3-karboksamida

Country Status (11)

Country Link
US (1) US11236070B2 (sl)
EP (1) EP3969445B1 (sl)
JP (1) JP7620572B2 (sl)
KR (1) KR102875297B1 (sl)
CN (1) CN114096529A (sl)
AU (1) AU2020275137B2 (sl)
CA (1) CA3140119A1 (sl)
ES (1) ES3014254T3 (sl)
IL (2) IL287919B2 (sl)
SI (1) SI3969445T1 (sl)
WO (1) WO2020230100A1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022206937A1 (zh) * 2021-04-01 2022-10-06 苏州晶云药物科技股份有限公司 一种吡唑取代的烟酰胺类化合物的盐酸盐新晶型及其制备方法
CN116135851B (zh) * 2021-11-17 2025-09-23 武汉众诚康健生物医药科技有限公司 一种芳香胺化合物及其应用
CN114369085B (zh) * 2021-12-27 2023-01-03 武汉九州钰民医药科技有限公司 盐酸Asciminib的制备方法
EP4615831A1 (en) * 2022-11-10 2025-09-17 Synthon B.V. Crystalline form of asciminib hydrochloride

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117662A1 (de) 1971-04-10 1972-10-19 Farbwerke Hoechst AG, vormals Meister Lucius & Brüning, 6000 Frankfurt Phenylharnstoffderivate, deren Herstellung und Verwendung als Herbizide
JPH02104571A (ja) 1988-10-13 1990-04-17 Kanegafuchi Chem Ind Co Ltd N−ベンジルピロリジン誘導体の製造方法
JPH02212469A (ja) 1989-02-10 1990-08-23 Kanegafuchi Chem Ind Co Ltd N―ベンジルピロリジン誘導体又はその塩の製造方法
US5739342A (en) 1997-03-03 1998-04-14 Abbott Laboratories Process for the preparation of nicotinic acids
US5916910A (en) 1997-06-04 1999-06-29 Medinox, Inc. Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
GB0309631D0 (en) 2003-04-28 2003-06-04 Bayer Cropscience Ag Novel process for the preparation of 2-aminomethylpyridine derivatives
EP1674455A1 (en) 2004-12-21 2006-06-28 Bayer CropScience S.A. Process for the preparation of a 2-ethylaminopyridine derivative
ES2326280T3 (es) 2005-04-06 2009-10-06 F. Hoffmann-La Roche Ag Derivados de piridin-3-carboxamida como agonistas inversos de cb1.
WO2009151991A1 (en) 2008-06-11 2009-12-17 Merck & Co., Inc. Pyrazole derivatives useful as inhibitors of faah
US20120101282A1 (en) 2010-10-22 2012-04-26 Pascal Dott Process for the preparation of nicotinamide derivatives
JP2013095742A (ja) 2011-11-07 2013-05-20 Manac Inc ブロモピリジン誘導体の製造方法
KR20150008406A (ko) 2012-05-15 2015-01-22 노파르티스 아게 Abl1, abl2 및 bcr-abl1의 활성을 억제하기 위한 벤즈아미드 유도체
ES2670601T3 (es) 2012-05-15 2018-05-31 Novartis Ag Derivados de benzamida para la inhibición de la actividad de ABL1, ABL2 y BCR-ABL1
CN104119238B (zh) 2013-04-26 2016-09-21 金凯(辽宁)化工有限公司 一种4-(一氯二氟甲氧基)苯胺的制备方法
DK3120852T3 (da) * 2015-01-30 2019-07-29 Taiho Pharmaceutical Co Ltd Præventivt og/eller terapeutisk middel til immunsygdomme
MY185488A (en) 2015-04-09 2021-05-19 Orion Corp Process for the preparation of androgen receptor antagonists and intermediates thereof
TWI726900B (zh) 2015-08-04 2021-05-11 美商陶氏農業科學公司 用於氟化化合物之過程
KR101830372B1 (ko) 2015-09-01 2018-02-20 삼성전자주식회사 냉장고
EP3416949A1 (en) * 2016-02-18 2018-12-26 Solvay Sa Process for the manufacture of carboxamides
KR101825065B1 (ko) * 2016-05-24 2018-02-05 한국화학연구원 Alk 단백질의 분해를 유도하는 약학적 조성물 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
US11353435B2 (en) 2018-05-24 2022-06-07 Iowa State University Research Foundation, Inc. Zwitterionic compounds as gas chromatographic column stationary phases
LT3841101T (lt) 2018-08-24 2023-06-26 Bayer Aktiengesellschaft 2-[(3r)-3-metilmorfolin-4-il]-4-[1-metil-1h-pirazol-5-il)-8-(1h pirazol-5-il)-1,7-naftiridino gavimo būdas

Also Published As

Publication number Publication date
KR20220009415A (ko) 2022-01-24
EP3969445B1 (en) 2024-11-27
CA3140119A1 (en) 2020-11-19
IL322253A (en) 2025-09-01
KR102875297B1 (ko) 2025-10-23
AU2020275137A1 (en) 2021-12-16
JP2022532232A (ja) 2022-07-13
ES3014254T3 (en) 2025-04-21
US20200361903A1 (en) 2020-11-19
IL287919B2 (en) 2026-01-01
IL287919A (en) 2022-01-01
IL287919B1 (en) 2025-09-01
WO2020230100A9 (en) 2024-08-22
EP3969445A1 (en) 2022-03-23
CN114096529A (zh) 2022-02-25
JP7620572B2 (ja) 2025-01-23
US11236070B2 (en) 2022-02-01
WO2020230100A1 (en) 2020-11-19
AU2020275137B2 (en) 2023-06-29

Similar Documents

Publication Publication Date Title
IL287995A (en) Crystalline forms of n-[4-(chlorodifluoromethoxy)phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-5-yl)pyridine-3-carboxamide
ZA202004692B (en) Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
IL255358B (en) Naphthyridine compounds as jak kinase inhibitors
NZ736999A (en) Processes and intermediates for the preparation of { 1-(ethylsulfonyl)-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]azetidin-3-yl} acetonitrile
IL249491A0 (en) Crystalline salts of (s)-6-((1-acetylpiperidin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidin-4- Carboxamide
IL262391B (en) Crystal forms of n-[2-(3-hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-h2-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
EP3250557A4 (en) Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
WO2013111163A3 (en) Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof
IL285299A (en) Method for preparing (3r,4s)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide
IL288593A (en) Processes for the preparation of aminopyrimidine compounds
GB2551925B (en) Improving quality of experience for communication sessions
ZA202002530B (en) Process for producing herbicidal pyridazinone compounds
PL3393972T3 (pl) Proces wytwarzania kompozycji zeolitu wymienianego żelazem (iii)
WO2020230100A9 (en) Process for the preparation of n-4-(chlorodifluoromethoxy)phenyl-6-(3r)-3-hydroxypyrrolidin- l-yl- 5-(lh-pyrazol-5-yl)pyridine-3-carboxamide
IL253239B (en) Process for preparing 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo[5,4[b-pyridin-2-yl)pyridin-2-amine
IL260748A (en) Heat-induced grafting of nonwovens for high capacity ion exchange separation
HK40061247A (en) Crystalline forms of n-[4-(chlorodifluoromethoxy)phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-5-yl)pyridine-3-carboxamide
ZA201303872B (en) Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines
WO2013192046A3 (en) Substituted picolinamide kinase inhibitors
PH12014500289B1 (en) Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride
IL239228A0 (en) Improved process for the preparation of n-cyano-s-[1-(pyridine-3-yl)ethyl]-s-methylsulfylamines
MX350575B (es) Procedimiento para la preparación de fenil y piridil pirrolidinas opcionalmente sustituidas.
IL249496B (en) Improved process for the preparation of 4-(1-(4-(perfluoroethoxy)phenyl-h1-1,2,4-(triazol-3-yl)benzoyl azide)